Daijiworld Media Network - Ahmedabad
Ahmedabad, Nov 16: The Narcotics Control Bureau (NCB), in a joint operation with Ahmedabad's Sarkhej police, has busted an alleged synthetic drug manufacturing unit operating from the basement of a residential house in Juhapura and arrested a man before he could deliver his first consignment.
The raid was conducted on November 15 under 'Operation Synthetic Drug'. Officials seized 26.85 grams of liquid mephedrone (MD), 0.70 grams of powdered MD and 130.613 kg of chemicals allegedly intended for manufacturing the synthetic drug.
The arrested accused has been identified as Mudassar Pathan, alias MM Pathan, who allegedly owned the house and was attempting to establish a drug manufacturing operation in its basement.

NCB Gujarat Zonal Director Ghanshyam Soni said the operation exposed an initial-stage MD manufacturing laboratory in a residential locality, where chemicals and equipment had been brought in to set up the facility.
“During the joint operation with the Sarkhej police, we discovered an MD manufacturing laboratory setup in the basement of the house, along with a substantial quantity of chemicals. One accused has been arrested. He owns the house and also operates Ratlam Cafe, which was subsequently searched as part of the investigation,” Soni said.
The seized chemicals included acetone, 2-bromo-4-bromamine and hydrochloric acid, which were allegedly procured for manufacturing mephedrone.
Pathan had reportedly been living in the house for around three years. Investigations revealed that he was initially a drug consumer before allegedly entering the narcotics trade as a peddler. He later attempted to move from selling drugs to manufacturing them.
Zone-7 Deputy Commissioner of Police Shivam Verma said Pathan had allegedly made repeated attempts to manufacture MD after learning about the process at a facility in Rajasthan and subsequently researching it online.
“He had observed a manufacturing process or facility in Pratapgarh, Rajasthan, and subsequently searched for the procedure on Google. He then attempted to replicate the process at his residence. He had been trying to manufacture MD for more than a year but had not succeeded in producing it on the desired scale,” Verma said.
The investigation also led officials to Ratlam Cafe, operated by Pathan near the route connecting the YMCA Club area with SP Ring Road. The NCB searched the establishment for nearly three hours and questioned an employee identified as Devram.
The employee reportedly informed investigators that the cafe had been operating at its present location for two years and was previously based in Makarba.
Soni said investigators were examining a possible Madhya Pradesh connection, particularly Mandsaur, and would investigate whether the cafe had any links to the suspected drug network.
“Since young people frequently visit the cafe, we will examine every possible angle. We are coordinating with the Gujarat Police and ATS to establish the source of the chemicals, identify potential suppliers and ascertain whether others were involved in the operation,” he said.
According to Verma, most of the raw materials had allegedly been procured locally from Ahmedabad, while some chemicals were sourced from Ratlam in Madhya Pradesh.
Pathan was allegedly attempting to manufacture high-quality MD, initially for his personal consumption, investigators said.
Although his wife was present in the house during the operation, preliminary investigations have not indicated her involvement in the alleged drug manufacturing activity, Verma said. Police are examining whether anyone else assisted Pathan, who is suspected to have operated the laboratory independently.
Investigators are also examining CCTV footage from cameras installed outside the house to reconstruct activities at the premises and establish whether other individuals visited the suspected manufacturing unit.
The NCB and Gujarat Police are continuing their investigation to identify the chemical suppliers, trace possible links with Madhya Pradesh and establish whether the accused was part of a larger synthetic drug network.